Trials / Completed
CompletedNCT05286385
CP1150 Sound Processor Speech Perception Compared With the Next Generation of Signal Processing Technology
A Pre-Marketing, Prospective, Single-Site, Open-Label, Within-Subject, Pilot, Interventional Study of Adult Cochlear Implant Speech Perception With the CP1150 Sound Processor Compared With the Next Generation of Signal Processing Technology
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Cochlear · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This clinical study aims to investigate speech performance in quiet with an OTE Sound Processor with modified firmware compared with the commercially available CP1150. The study also investigates CP1110 and CP1150 with Forward Focus.
Detailed description
This study will build on the evidence previously collected on OTE and BTE Sound Processors and will support the design goals for access to the same sound processing algorithms across future OTE and BTE variants, including evidence required on the automation of FF and future implant compatibility.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CP1150 Sound Processor | Speech perception tests whilst the subject is fitted with the CP1150 Sound Processor |
| DEVICE | CP1150 NF | Speech perception tests whilst the subject is fitted with the CP1150 modified firmware (the addition of notch filters at 978Hz, 1956Hz, 2934Hz, 3912Hz). |
| DEVICE | CP1150 + FF | Speech perception tests whilst the subject is fitted with the CP1150 Sound Processor with ForwardFocus. |
| DEVICE | CP1110 | Speech perception tests whilst the subject is fitted with the CP1110 Sound Processor. |
Timeline
- Start date
- 2022-05-30
- Primary completion
- 2022-06-29
- Completion
- 2022-06-29
- First posted
- 2022-03-18
- Last updated
- 2025-02-07
- Results posted
- 2024-08-05
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT05286385. Inclusion in this directory is not an endorsement.